45 related articles for article (PubMed ID: 8466892)
1. Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.
Ongini E; Impagnatiello F; Bonazzi A; Guzzetta M; Govoni M; Monopoli A; Del Soldato P; Ignarro LJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8497-502. PubMed ID: 15173604
[TBL] [Abstract][Full Text] [Related]
2. Selected statins produce rapid spinal motor neuron loss in vitro.
Murinson BB; Haughey NJ; Maragakis NJ
BMC Musculoskelet Disord; 2012 Jun; 13():100. PubMed ID: 22703530
[TBL] [Abstract][Full Text] [Related]
3. Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation.
Busnelli M; Manzini S; Sirtori CR; Chiesa G; Parolini C
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200592
[TBL] [Abstract][Full Text] [Related]
4. Effects of fluvastatin on plasma levels of low-density lipoprotein subfractions, oxidized low-density lipoprotein, and soluble adhesion molecules: a twenty-four-week, open-label, dose-increasing study.
Homma Y; Homma K; Iizuka S; Iigaya K
Curr Ther Res Clin Exp; 2003 Apr; 64(4):236-47. PubMed ID: 24944371
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin reduces neointima formation in a rat model of balloon injury.
Preusch MR; Vanakaris A; Bea F; Ieronimakis N; Shimizu T; Konstandin M; Morris-Rosenfeld S; Albrecht C; Kranzhöfer A; Katus HA; Blessing E; Kranzhöfer R
Eur J Med Res; 2010 Nov; 15(11):461-7. PubMed ID: 21159570
[TBL] [Abstract][Full Text] [Related]
6. Temporal gene expression analysis of human coronary artery endothelial cells treated with Simvastatin.
Zhang LQ; Ma SF; Grigoryev D; Lavoie TL; Xiao HQ; Setterquist R; Li H; Jacobson J; Garcia JG; Ye SQ
Gene Expr; 2008; 14(4):229-39. PubMed ID: 19110722
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin: clinical and safety profile.
Corsini A; Jacobson TA; Ballantyne CM
Drugs; 2004; 64(12):1305-23. PubMed ID: 15200346
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory and immunomodulatory properties of statins.
Shovman O; Levy Y; Gilburd B; Shoenfeld Y
Immunol Res; 2002; 25(3):271-85. PubMed ID: 12018465
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of fluvastatin.
Scripture CD; Pieper JA
Clin Pharmacokinet; 2001; 40(4):263-81. PubMed ID: 11368292
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of statins.
Farmer JA
Curr Atheroscler Rep; 2000 May; 2(3):208-17. PubMed ID: 11122746
[TBL] [Abstract][Full Text] [Related]
11. Current, new and future treatments in dyslipidaemia and atherosclerosis.
Chong PH; Bachenheimer BS
Drugs; 2000 Jul; 60(1):55-93. PubMed ID: 10929930
[TBL] [Abstract][Full Text] [Related]
12. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
Shiomi M; Ito T
Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
[TBL] [Abstract][Full Text] [Related]
13. Are there potential non-lipid-lowering uses of statins?
Wheeler DC
Drugs; 1998 Oct; 56(4):517-22. PubMed ID: 9806100
[TBL] [Abstract][Full Text] [Related]
14. T-lymphocytes and monocytes in atherogenesis.
Schmitz G; Herr AS; Rothe G
Herz; 1998 May; 23(3):168-77. PubMed ID: 9646098
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.
Plosker GL; Wagstaff AJ
Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381
[TBL] [Abstract][Full Text] [Related]
16. Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits.
Soma MR; Donetti E; Seregni R; Barberi L; Fumagalli R; Paoletti R; Catapano AL
Br J Pharmacol; 1996 May; 118(2):215-9. PubMed ID: 8735617
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.
Plosker GL; McTavish D
Drugs; 1995 Aug; 50(2):334-63. PubMed ID: 8521762
[TBL] [Abstract][Full Text] [Related]
18. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
Soma MR; Donetti E; Parolini C; Mazzini G; Ferrari C; Fumagalli R; Paoletti R
Arterioscler Thromb; 1993 Apr; 13(4):571-8. PubMed ID: 8466892
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of isoprenoid biosynthesis and arterial smooth-muscle cell proliferation.
Soma MR; Parolini C; Donetti E; Fumagalli R; Paoletti R
J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S20-4. PubMed ID: 8907210
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]